Regulatory & Compliance

Biotechnology | Healthcare | Life Sciences

James N. Czaban, Sonali P. Gunawardhana | Wiley Rein LLP

Editor: Ms. Gunawardhana, please tell our readers about your background at the FDA. Gunawardhana: I started my career at the FDA in 2003, as a regulatory counsel in the Center for Devices and Radiological Health (CDRH) in the Division of Bioresearch Monitoring within the Office of...

Finance | Private Equity

Heath P. Tarbert, Sunny J. Thompson, Robert J. Lemons, Michael Horowitz, Eric J. Peterman, Ariel Kronman, Hyun K. Kim, David E. Wohl, Richard I. Ellenbogen, John J. Dedyo, Shawn Kodes, Adia Goss, Brian A. Waldbaum, Walter E. Zalenski, Timothy C. Welch, Christian Bartholomew, Sarah S. Nilson, Holly J. Gregory, Rebecca C. Grapsas | Weil, Gotshal & Manges LLP

Editor’s Note: This report discusses steps to reduce the likelihood of a future recession and is therefore of great importance to all our readers. Our thanks go to Weil, Gotshal & Manges LLP and its Financial Regulatory Reform Working Group for their efforts. ...

International Trade

Wynn H. Segall | Akin Gump Strauss Hauer & Feld LLP

Editor: Please tell us about the investigation of Standard Chartered for violations of U.S. sanctions against Iran. What are the major allegations, and where does the matter stand at present? Segall: The Department of Financial Services in New York (DFS) – a state regulatory agency...